Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Conditions

Hepatitis B 4Lymphoma 3Carcinoma, Hepatocellular 3Recurrence 1Lymphoma, Non-Hodgkin 1Liver Neoplasms 1Arthritis, Rheumatoid 1

Interventions

Adalimumab 10Etanercept 9Methotrexate 4Infliximab 3tofacitinib 2Rituximab 2Leflunomide 2Abatacept 2tocilizumab 1sarilumab 1golimumab 1entecavir 1Tumor Necrosis Factor Inhibitors 1Sulfasalazine 1Prednisone 1Licensure 1Hydroxychloroquine 1Glucocorticoids 1Folic Acid 1Chloroquine 1Certolizumab Pegol 1Azathioprine 1Antirheumatic Agents 1Anti-Inflammatory Agents, Non-Steroidal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Arthritis, Rheumatoid × entecavir × Clear all
NCT01907230 2019-03-13

Entecavir for Biological Agents Associated HBV Reactivation in Inflammatory Arthritis Patients

Taipei Veterans General Hospital, Taiwan

Phase 4 Unknown
115 enrolled

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡